Chargement des cours...
Prévisions
L'objectif de cours moyen des analystes est de 32,62€ (+29.554,55%). La médiane est de 32,62€ (+29.554,55%).
| Acheter |
4 |
| Conserver |
1 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
BiomX buys 10% of Motomea and secures exclusive drone test license
BiomX acquires a 10 percent stake in M.E.A. Testing Systems Ltd. and Mea Motomova India for US$50,000 and obtains an exclusive license to develop and distribute testing solutions for drones. Motomea will issue 1,300,000 restricted shares to the majority holder; the transaction is subject to regulatory and NYSE American approval. BiomX received an option to acquire a controlling majority, with the purchase price to be set based on two times net revenue in 2027 and four times EBITDA in 2028 (multiplied by 90%), payable in shares and cash. Motomea has supplied patented test systems for electric motors for over 25 years, serving aerospace, automotive, industrial, energy and transport sectors; BiomX views this as a complement to its threat-detection and defense activities with expansion potential on the Indian subcontinent. » Plus sur de.investing.com
BiomX extends payment deadline for Zorronet takeover and issues shares
BiomX extends the maturity of a promissory note of $1.25 million related to the Zorronet acquisition to November 1, 2026, and agrees an initial repayment of $250,000 followed by four monthly installments of $250,000 each. As consideration and to settle accrued interest, BiomX will issue 800,000 restricted common shares to Water.IO; the issuance is subject to customary approvals. The company warns of risks, including possible non‑approval of the share issuance on the NYSE American, insufficient funds for remaining payments, compliance with listing standards, and a going‑concern notice. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | juin 2026 | |
|---|---|---|
| Chiffre d'affaires | 290,90k | - |
| Bénéfice brut | 84,99k | 134,31% |
| Bénéfice net | −3,31M | 35,47% |
| EBITDA | −3,34M | 31,02% |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 1,18M€ |
Nombre d'actions | 10,15M |
Plus haut/bas sur 52 semaines | 10,55€ - 0,10€ |
| Dividendes | Non |
Bêta | 1,37 |
Ratio P/E | −0,01 |
Ratio PEG | 0,00 |
Ratio P/B | 0,13 |
Ratio P/S | 4,13 |
Profil de l'entreprise
| Nom | BIOMX INC. NEW |
| PDG | Michael Oster |
| Employés | 20 |
Découvrir des actifs
Les actionnaires de BIOMX INC. NEW investissent également dans les actifs suivants



